Skip to Content
  • Previous Rank176
  • Revenues ($M)15,879
  • Revenue Percent Change-3.1%
  • Profits ($M)2,004
  • Profits Percent Change-21.8%
  • Market Value (as of March 31, 2015)107,500

The biopharmaceutical company manufactures medicines for Alzheimer’s, dementia, pyschiatric disorders, cardiovascular, diabetes, oncology, and hepatitis.

Fortune Data StoreLooking for leads, investment insights, or competitive intelligence?Get Premium Access

Company Info

CEO
Giovanni Caforio
Industry
Pharmaceuticals
Sector
Health Care
HQ Location
New York, NY
Websitehttp://www.bms.com
Years on List21

Key Financials (last fiscal year)

$ millions% change
Revenues ($M)15,879-3.1%
Profits ($M)2,004-21.8%
Total Stockholder Equity14,852-
Employees25,000-
Market Value (as of March 31, 2015)107,500-

Profit Ratios

Profit as % of Revenues12.6%
Profits as % of Assets5.9%
Profits as % of Stockholder Equity13.5%

Earnings Per Share (last fiscal year)

Earnings Per Share ($)1.2
EPS % Change (from 2013)-22.1%
EPS % Change (5 year annual rate)-25.8%
EPS % Change (10 year annual rate)-0.1%

Total Return

Total Return to Investors (2014)14.2%
Total Return to Investors (5 year, annualized)23.3%
Total Return to Investors (10 year, annualized)13.6%